The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Grafoid and Mitsui Sign MOU to Identify & Develop Markets for MesoGraf™ Graphene in Japan
Mar. 26, 2014 11:30AM PST
Battery MetalsGrafoid Inc. and Mitsui & Co., Ltd. have signed a 2-year agreement to identify and develop market opportunities in Japan for MesoGraf™, the first universally trademarked graphene.
As quoted in the press release:
The two-year agreement was signed by Grafoid CEO and co-founder Gary Economo and by Mr. Takeo Kato, General Manager of Advanced Material Division of Mitsui.
The agreement calls for the parties to jointly undertake a one-year detailed market feasibility study to identify and evaluate market opportunities prior to formalizing industrial and commercial development projects in Japan.
Grafoid Inc. CEO and Co-Founder, Gary Economo, said:
The MOU recognizes both companies’ willingness to pursue business opportunities that focus on and lead to the commercialization of MesoGraf™ in the Japanese market.
Click here to read the Grafoid Inc. press release
Sign up for the free eBook: Graphene – Investing in The Future
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.